Qualium Investissement, an investment company, and Lauxera Capital Partners, an asset manager, completed the acquisition of a majority stake in VERDOT Ips²,a company designs and manufactures of purification solutions by liquid chromatography and tangential filtration, from Capital Export, an international freight forwarding company. Financial terms were not disclosed. "VERDOT Ips² has nearly 30 years of innovation and expertise in the field of healthcare. We are delighted to accompany the management in this new phase of deployment, in a market driven by the increase of R&D expenses and a strong pipeline of molecules in preclinical and clinical trials," Pierre Moustial, Lauxera Capital Partners Founder.